96 Spadina Avenue
Toronto, ON M5V 2J6
Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees: 445
|Mr. Jeffrey Fallows C.F.A., L.L.B., M.B.A., CFA||Pres||392.74k||N/A||N/A|
|Mr. Sunil Gandhi CPA||Chief Financial Officer||161.23k||N/A||N/A|
|Ms. Chantel Popoff||Chief Operating Officer||310.08k||N/A||N/A|
|Mr. Adam Shea||Chief Commercial Officer||155.28k||N/A||N/A|
|Mr. Scott Young||Head of Investor Relations||N/A||N/A||N/A|
|Mr. Everett Knight C.F.A.||Exec. VP of Corp. Devel. & Capital Markets||N/A||N/A||N/A|
|Mr. Anderson Smith||Head of Regulatory Affairs||N/A||N/A||N/A|
|Mr. Daniel Howard||VP, Bus. Devel.||N/A||N/A||N/A|
The Valens Company Inc., through its subsidiaries, develops, manufactures, and sells cannabinoid-based products in Canada, the United States, and internationally. The company provides packaged dried flower/pre-rolls under the Verse, Versus, Contraband, and Citizen Stash brands; vapourizers and hydrocarbon extracts under the Verse and Versus brands; edible cannabis products under the Verse, Vacay, and LYF brands; and topical cannabis under the Nuance brand. It also offers analytical testing services to third party licensed producers in the cannabis space. The company is headquartered in Toronto, Canada.
The Valens Company Inc.’s ISS Governance QualityScore as of September 1, 2022 is 8. The pillar scores are Audit: 10; Board: 5; Shareholder Rights: 7; Compensation: 9.